Who backs Kinaset Therapeutics?
12 investors| Investor | Type |
|---|---|
| RA Capital Management | Asset manager |
| SV Health Investors | Venture capital |
| EQT Life Sciences | Venture capital |
| Schroders Capital | Other |
| Vivo Capital | Venture capital |
| Atlas Venture | Other |
| 5AM Ventures | PE / buyout |
| Willett Advisors | Family office |
| Pictet Alternative Advisors | Asset manager |
| Forge Life Science Partners | — |
| + 2 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Kinaset Therapeutics investors
12 investors are on record for Kinaset Therapeutics, including RA Capital Management, SV Health Investors, EQT Life Sciences and Schroders Capital. By type, the record holds 3 venture capital firms and 2 asset managers. The Series B in Jan 2026 drew 11 investors.
Free account
More of Kinaset Therapeutics with a free account
- ·The complete investor list: 12 names
- ·Watch Kinaset Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 12 firms already write checks for companies like Kinaset Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View